Page last updated: 2024-08-25

bufuralol and Parkinson Disease

bufuralol has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bargetzi, MJ; Fonne-Pfister, R; Meyer, UA	1

Other Studies

1 other study(ies) available for bufuralol and Parkinson Disease

Article	Year
MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochemical and biophysical research communications, 1987, Nov-13, Volume: 148, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antibodies, Monoclonal; Brain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Ethanolamines; Humans; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; Parkinson Disease; Pyridines; Rats	1987

Article

Year

MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation.

Biochemical and biophysical research communications, 1987, Nov-13, Volume: 148, Issue:3

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antibodies, Monoclonal; Brain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Ethanolamines; Humans; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; Parkinson Disease; Pyridines; Rats

1987